期刊文献+

血浆脂蛋白相关磷脂酶A2在冠状动脉病变患者中的临床应用价值 被引量:3

Clinical application value of plasma lipoprotein associated phospholipase A2 in patients with coronary arterial lesions
下载PDF
导出
摘要 目的探讨血浆脂蛋白相关磷脂酶A2(lipoprotein associated phospholipaseA2,Lp-PLA2)在冠状动脉病变患者中的临床应用价值。方法2015年8月至2016年4月期间,选取四川成都市第五人民医院进行冠状动脉造影的患者187例进行研究,分析其基本情况、冠状动脉病变支数、Gensini积分、临床类型等分别对Lp-PLA2浓度及冠状动脉血流参数[左前降支收缩期峰流速(systolicpeakvelocity,SPV)、舒张期峰流速(diastolic peak velocity,DPV)、冠状动脉窦舒张期逆行心房波最大流速(A)、冠状动脉血流储备(coronary flow velocity reserve,CFVR)、舒张期时间速度积分(diastolic time velocity integral,CTVI)]的影响,分析Lp-PLA2浓度与冠状动脉血流参数的相关性,综合分析各因素对Lp-PLA2浓度的影响。结果急性冠状动脉综合征患者慢性疾病史、冠状动脉病变支数、Gensini积分、临床分型对Lp-PLA2浓度和冠状动脉血流参数(SPV、A、CFVR)影响显著(P<0.05);Lp-PLA2浓度与冠状动脉血流参数SPV、DPV、A、CFVR、CTVI分别呈正相关关系(r=18.635、14.633、17.308、19.647、15.887,P=0.000);以Lp-PLA2浓度为因变量,各影响因素进行拟合,有4个因素(慢性疾病史、病变支数、Gensini积分、临床分型)进入回归方程。结论血浆Lp-PLA2浓度对于早期诊断急性冠状动脉综合征有一定临床价值,其可以在一定程度上反映患者的冠状动脉粥样硬化程度等基本病情。 Objectives To explore the clinical value of plasma lipoprotein associated phospholipase A2(Lp-PLA2)in patients with coronary artery disease.Methods During August 2015 to April 2016,187 patients performed coronary angiography were selected in The Fifth People′s Hospital of Chengdu as research objects.Effects of basic situation, coronary artery lesion counts,Gensini score,clinical types on concentration of Lp-PLA2 and coronary blood flow parameters[systolic peak velocity(SPV),diastolic peak velocity(DPV),maximum velocity of retrograde atrial wave in diastolic phase of coronary sinus(A),coronary flow velocity reserve(CFVR),diastolic time velocity integral(CTVI)].Correlations of coronary blood flow parameters and concentration of Lp-PLA2 was analyzed.Effects of various factors on concentration of Lp-PLA2 were also analyzed.Results In patients with acute coronary syndrome,history of chronic disease,number of coronary artery lesion,Gensini score and clinical classification significantly affected concentration of Lp-PLA2 and coronary blood flow parameters(SPV,A,CFVR)(P<0.05).Coronary blood flow parameters(SPV,DPV,A,CFVR,CTVI)positively corrected with concentration of Lp-PLA2(r=18.635,14.633,17.308, 19.647,15.887;P=0.000).There were 4 factors(chronic disease history,lesion count,Gensini score and clinical classification)entering the regression equation with concentration of Lp-PLA2 as the dependent variable and the influencing factors fitted.Conclusions Concentration of Lp-PLA2 has certain clinical value for early diagnosis of acute coronary syndrome,which can reflect the degree of atherosclerosis to a certain extent.
作者 黄禄勇 付华莉 HUANG Lu-yong;FU Hua-li(Department of Cardiology,The Fifth People′s Hospital of Chengdu,Chengdu 611130,China)
出处 《岭南心血管病杂志》 2019年第5期514-518,共5页 South China Journal of Cardiovascular Diseases
关键词 冠状动脉疾病 脂蛋白相关磷脂酶A2 冠状动脉造影 coronary artery disease lipoprotein related phospholipase A2 coronary angiography
  • 相关文献

参考文献13

二级参考文献118

  • 1孙彦彦,邱春光,韩战营,卢文杰,王卫平,邱承杰,杨长宝,陈晓杰.脂蛋白相关磷脂酶A2与冠状动脉粥样硬化病变程度及斑块稳定性的关系[J].中国实用医刊,2010,37(4):39-41. 被引量:7
  • 2刘甲兴,郑兴.脂蛋白相关磷脂酶A2与动脉粥样硬化[J].中国动脉硬化杂志,2006,14(3):274-276. 被引量:14
  • 3马增煌,陈丽峰,胡芳,王弘,程学强.脂蛋白(a)水平与腔隙性脑梗死关系的临床研究[J].微循环学杂志,2007,17(1):73-73. 被引量:4
  • 4Oei H H, Vander Meer IM, ttofman A, et al. I.ipoprotein-associat- e3 phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the rotterdam study[J]. Circu lation, 2005,111 (5) : 570-575.
  • 5Winkler K, Hoffmann MM, Winkelmann BR, et al. Lipoprotein associated phospholipase A2 predicts 5 year cardiac mortality in- dependently of established risk factors and adds prognostic infor marion in patients with low and medium high sensitivity C-reac- tive protein[J]. Clin Chem,2007,53(8) : 1440 -1447.
  • 6Garza CA, Montori VM, McConnell JP, et al. Association between IApoprotein-associated phospholipase A2 and cardiovascular dis- ease:a systematic review[J]. Mayo Clin Proc, 2007,82 (2) : 159- 165.
  • 7Papathanasiou AI, Lourida I.D, et al. Short-and long term eleva- tion of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein associated phospholipase A2 and the effect of atorvastatintreatment[J]. A therosclerosis,2008,196(2) :289 -297.
  • 8Anuurad E,Ozturk Z,Enkhmaa B,et al. Association of l.ipopro- rein-associated phospholipase A2 with coronary artery disease in african Americans[J]. Clin Endocrinol, 2010,95 ( 23 ) : 2376-2383.
  • 9Sachdeva A,Cannon CP, Deedwania PC, et al. Lipid levels in pa- tients hospitalizaed with coronary artery disease: an analysis of 136,905 hospitalizations in get with the guidelines[J]. Am Heart J,2009,157(1) : 111-117.
  • 10Brilakis ES, McConnell JP, l.ennon RJ, et al. Association of lipo protein associated phospholipase A2 levels with coronary disease risk factors, angiograpbic coronary artery disease, and major ad verse events at follow upJT. Eur tteart J,2005,26(2) :137- 144.

共引文献103

同被引文献31

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部